🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

🧪

Trial Match

Clinical trials test new treatments — sometimes the newest options available for a disease. Find trials that are recruiting now, near you. Open one to see its eligibility rules as simple questions to go through with your doctor.

Know your stage or your test results (such as EGFR, HER2 or BRCA)? Match trials to your own profile - nothing you type is saved.

🎯 Match trials to me

11 recruiting trials

for PSA Progression

MRI-Assisted Guidance for Non-Essential Tissue Sampling NCT07516223NA1 site📍 Shanghai Shanghai East Hospital · Tests: Paired Prostate Biopsy Cohort (TB + SB) Safety and Efficacy of AGN-INM176 in Prostate Patients With Rising PSA NCT06600698Phase 1, Phase 21 site📍 Hershey Milton S. Hershey Medical Center · Tests: INM176 Multiparametric Magnetic Resonance Imaging of the Prostate to Assess Disease Progression and Genomics in Patients Undergoing Active Surveillance for Prostate Cancer NCT04692675NA1 site📍 Bethesda National Cancer Institute (NCI) · Tests: mpMRI Oxidative Stress in Autoimmune Rheumatic Diseases NCT07536529n/a1 site📍 Larissa University of Thessaly Upright MRI for Prostate Cancer Screening NCT03474913n/a1 site📍 New York Icahn School of Medicine at Mount Sinai · Tests: Upright MRI, Standard MRI Prostate Risk Or Radiology Assessment Non-inferiority Design, Upfront MRI or Risk Calculator in Men With Suspected Prostate Cancer NCT07422597NA3 sites📍 Levanger📍 Orkanger📍 Trondheim Norwegian University of Science and Technology · Tests: European Study of screening for prostate cancer risk calculator PET Scan Study to Detect Prostate Cancer in Patients with Early PSA Recurrence NCT06617481Phase 21 site📍 Orlando AdventHealth · Tests: 18F-rhPSMA-7.3 (Posluma) The Study of 177Lu-TLX591 Plus SOC Versus SOC Alone in Patients With mCRPC (ProstACT Global) NCT06520345Phase 333 sites📍 Orange📍 Miami📍 Glen Burnie Telix Pharmaceuticals (Innovations) Pty Limited · Tests: 177Lu-TLX591, Enzalutamide, Abiraterone, Docetaxel Talazoparib Plus Enzalutamide After Progression to Prior ARPi in Metastatic Prostate Cancer NCT06582628Phase 219 sites📍 Bordeaux📍 Brest📍 Lille Fundacion Oncosur · Tests: Enzalutamide capsule, Enzalutamide capsule and Talazoparib capsule Saruparib in Combination With Physician's Choice of ARPI in Patients With mHSPC Previously Treated With Docetaxel or 177Lu-PSMA Therapy Without Disease Progression and PSA ≥ 0.2 ng/mL (EvoPAR-PR05) NCT07711002Phase 3210 sites📍 Hot Springs📍 Springdale📍 Beverly Hills AstraZeneca · Tests: Saruparib, Placebo, Enzalutamide, Darolutamide, Abiraterone Working Out M0 Bipolar Androgen Therapy NCT06594926Phase 212 sites📍 Garran📍 Albury📍 Darlinghurst Australian and New Zealand Urogenital and Prostate Cancer T… · Tests: Testosterone Enanthate
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy